FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Averix Bio that will bring U.S.-produced API phytocannabinoid ingredients and ...
GUANGHAN, CHINA / ACCESSWIRE / August 20, 2021 / On April 27, Zhang Ge, Board Chairman and President of Sichuan Deebio Pharmaceutical Co., Ltd. (hereinafter referred to as Deebio), participated in the ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...
Sharon Bio-Medicine today said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra. The company, however, said it cannot start supplying to the US market ...
A Japanese API maker told the FDA that it had a “lack of awareness of the seriousness” of its GMP violations after admitting to the agency that it had manipulated data during its API testing. The ...
API-192 is a first-in-class off-the-shelf allogeneic CAR-NKT cell therapy that expresses dual CARs targeting CD19 and CD20 and armored with soluble IL-15 for improved expansion and persistence API-192 ...
A China-based manufacturer of active pharmaceutical ingredients (API) suspended producing API for the U.S. market following an FDA inspection that found “significant deviations” from good ...
Flow chemistry for the production of small-molecule APIs is recognized to offer significant benefits, particularly for processes that involve hazardous reagents or that are highly exothermic. The ...
Sharon Bio-Medicine today said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra. The company, however, said it cannot start supplying to the US market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback